跳至主要内容
临床试验/IRCT201202011965N2
IRCT201202011965N2已完成未知

?Effect of Dronedarone on prevention of atrial fibrilation after on-pump coronary bypass graft surgery

Vice chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 no limit(—)
性别
All

入选标准

  • Age over 20 years; the first time, On-pump CABG
  • Exclusion criteria: Previous history of AF / AFL; AV block grade 2 and above; Sinus bradycardia with heart rate below 60 bpm; Hemodynamic instability (SBP <100 mmHg); Use of class I or III antiarrhythmia drugs and the other drugs that increase the QT; Uncontrolled heart failure (NYHA class III or IV); Severe liver disease; Valve replacement surgery at the same time; Hypercalemia (K <3.5 mmol / L) or uncontrolled hypermagnesiumia; Severe renal insufficiency (GFR <10 ml / min); Pregnancy and lactation; Amiodarone injection during CABG

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tehran University of Medical Sciences

相似试验

?Effect of Dronedarone on prevention of atrial... | 临床试验